Analyst Ratings for Allscripts (MDRX) [Neutrals]
MDRX Rating Summary
MDRX Price Target Summary
- Highest: $25.00 (Deutsche Bank)
- Lowest: $7.00 (Piper Jaffray)
- Average: $13.73
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$13.73 (+1.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/4/2013 | Goldman Sachs | New Coverage | Neutral (N/A) |
15.00 (N/A) |
13.76 | 13.57 | -1.38% | Details |
| 4/18/2013 | Maxim Group | Downgrade | Hold (Buy) |
N/A (N/A) |
12.93 | 13.57 | 4.95% | Details |
| 3/28/2013 | B. Riley | New Coverage | Neutral (N/A) |
11.50 (N/A) |
13.64 | 13.57 | -0.51% | Details |
| 12/21/2012 | Argus | Downgrade | Hold (Buy) |
N/A (N/A) |
9.14 | 13.57 | 48.47% | Details |
| 11/27/2012 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
12.36 | 13.57 | 9.79% | Details |
| 5/30/2012 | Wells Fargo | New Coverage | Market Perform (N/A) |
12.00 (N/A) |
11.21 | 13.57 | 21.05% | Details |
| 5/23/2012 | Lazard Capital | New Coverage | Hold (N/A) |
N/A (N/A) |
11.20 | 13.57 | 21.16% | Details |
| 4/30/2012 | William Blair | Downgrade | Market Perform (N/A) |
N/A (N/A) |
10.30 | 13.57 | 31.75% | Details |
| 4/27/2012 | Oppenheimer | Downgrade | Perform (N/A) |
N/A (N/A) |
9.50 | 13.57 | 42.84% | Details |
| 4/27/2012 | Barclays | Downgrade | Equalweight (N/A) |
12.00 (N/A) |
9.50 | 13.57 | 42.84% | Details |
| 4/27/2012 | UBS | Downgrade | Neutral (N/A) |
N/A (N/A) |
9.50 | 13.57 | 42.84% | Details |
| 4/27/2012 | Caris & Co. | Downgrade | Average (N/A) |
11.00 (N/A) |
9.50 | 13.57 | 42.84% | Details |
| 4/27/2012 | Jefferies » Updated 2/20/2013 |
Downgrade | Hold (N/A) |
11.50 (10.00) |
9.50 | 13.57 | 42.84% | Details |
| 3/29/2012 | Auriga | Downgrade | Hold (N/A) |
19.00 (N/A) |
17.24 | 13.57 | -21.29% | Details |
| 2/21/2012 | Leerink Swann » Updated 6/18/2012 |
Downgrade | Market Perform (N/A) |
10.00 (N/A) |
19.54 | 13.57 | -30.55% | Details |
